CVS Health(CVS)
Search documents
Should You Pick CVS Stock At $55?
Forbes· 2024-08-15 11:00
AUSTIN, TEXAS - AUGUST 07: The exterior of a CVS pharmacy store is seen on August 07, 2024 in ... [+] Austin, Texas. CVS Health's medicare business continued to struggle financially in the second quarter, prompting further implementation of a $2 billion cost-cutting plan and the removal of a top executive. (Photo by Brandon Bell/Getty Images)Getty ImagesCVS Health (NYSE: CVS) has seen its stock fall around 4% in a week, aligning with the performance for its peer, Walgreens stock. The CVS Health stock price ...
CVS Health Corporation Class Action: The Gross Law Firm Reminds CVS Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 10, 2024 - CVS
Prnewswire· 2024-08-15 09:45
NEW YORK, Aug. 15, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of CVS Health Corporation (NYSE: CVS).Shareholders who purchased shares of CVS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=95557&from=4CLASS PERIOD: May 3, 202 ...
CVS Health Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 10, 2024 to Discuss Your Rights – CVS
GlobeNewswire News Room· 2024-08-14 16:23
NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CVS investors who were adversely affected by alleged securities fraud between May 3, 2023 and April 30, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/cvs-health-corporation-lawsuit-submis ...
The Gross Law Firm Notifies Shareholders of CVS Health Corporation (CVS) of a Class Action Lawsuit and an Upcoming Deadline
GlobeNewswire News Room· 2024-08-13 16:37
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of CVS Health Corporation (NYSE: CVS). Shareholders who purchased shares of CVS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=95121&from=3 CLASS PERIOD: Ma ...
1 Beaten-Down Stock to Buy and 2 to Avoid
The Motley Fool· 2024-08-13 10:45
One of these stocks is not like the others.It's best to buy stocks when they are down, as one of the most famous investing maxims tells us: "Buy low, sell high." However, companies going through a rough patch on the market aren't automatic buys. It's essential, as always, to separate the wheat from the chaff. Though broader equities have been performing well for most of the year, there are enough beaten-down stocks to choose from these days.Let's discuss three of them: One that looks attractive is CVS Healt ...
The Zacks Analyst Blog CVS Health, Walgreens and Herbalife
ZACKS· 2024-08-09 09:31
For Immediate ReleasesChicago, IL – August 9, 2024 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: CVS Health (CVS) , Walgreens Boots (WBA) and Herbalife (HLF) .Here are highlights from Friday’s Analyst Blog:What is the Right Approach for CVS Health (CVS Quick Quote - Free Report) Post Q2 Results?Yesterday, CVS ...
CVS: Growing Digital Reach Contributes to Revenue Growth
PYMNTS.com· 2024-08-08 01:17
CVS Health grew its revenues by 2.6% in the second quarter, crediting this year-over-year improvement in part to its growing number of digital customers, its offering of biosimilar prescriptions and its closure of underperforming stores.“We extended our digital reach with nearly 60 million unique digital customers utilizing our platform to schedule health services appointments, fill prescriptions and purchase wellness products — all contributing to the growth in our business,” CVS Health President and CEO K ...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 10, 2024 in CVS Health Corporation Lawsuit – CVS
GlobeNewswire News Room· 2024-08-07 17:21
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of CVS Health Corporation (NYSE: CVS). Shareholders who purchased shares of CVS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=94057&from=3 CLASS PERIOD: Ma ...
CVS Health(CVS) - 2024 Q2 - Earnings Call Transcript
2024-08-07 16:06
CVS Health Corporation (NYSE:CVS) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET Company Participants Karen Lynch - President, Chief Executive Officer Tom Cowhey - Executive Vice President, Chief Financial Officer Prem Shah - Executive Vice President, Chief Pharmacy Officer David Joyner - Executive Vice President, CVS Health Larry McGrath - Senior Vice President, Investor Relations Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Ann Hy ...
CVS Health Stock Drops After Cutting Profit Forecast Again
Kiplinger.com· 2024-08-07 15:04
CVS Health (CVS) stock is in negative territory Wednesday after the pharmacy chain and healthcare benefits provider reported mixed results for its second quarter and slashed its full-year profit forecast.In the three months ended June 30, CVS said its revenue increased 2.6% year-over-year to $91.2 billion, driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments. However, its earnings per share (EPS) decreased 17.2% from the year-ago period to $1.83, primarily due to a decline ...